-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
X4 Pharmaceuticals, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2016 to 2023.
- X4 Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was $90.8M.
- X4 Pharmaceuticals, Inc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was $17.6M.
- X4 Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$101M, a 7.78% decline from 2022.
- X4 Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$93.9M, a 5.83% decline from 2021.
- X4 Pharmaceuticals, Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$88.7M, a 42.8% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)